| Design, synthesis, and evaluation of Bothrops venom serine protease peptidic inhibitors GM Silva, DHB Souza, KB Waitman, MC Ebram, MR Fessel, IC Zainescu, ... Journal of Venomous Animals and Toxins including Tropical Diseases 27, e20200066, 2021 | 9 | 2021 |
| Synergistic effect of serine protease inhibitors and a bothropic antivenom in reducing local hemorrhage and coagulopathy caused by Bothrops jararaca venom GM Silva, DH Berto, CA Lima, KB Waitman, CFG Lima, BC Prezoto, ... Toxicon 199, 87-93, 2021 | 6 | 2021 |
| New kinase and HDAC hybrid inhibitors: recent advances and perspectives K Waitman, R Parise-Filho Future Medicinal Chemistry, 2022 | 2 | 2022 |
| HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents KB Waitman, LC de Almeida, MC Primi, JAEG Carlos, C Ruiz, ... European Journal of Medicinal Chemistry 263, 115935, 2024 | | 2024 |
| 1, 3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors MT Tavares, A Krüger, SLR Yan, KB Waitman, VM Gomes, DS de Oliveira, ... Scientific Reports 13 (1), 21006, 2023 | | 2023 |
| NOVEL POTENTIAL HDAC INHIBITOR INDUCES CELL DIFFERENTIATION IN ACUTE MYELOID LEUKEMIA CELLS J Carlos, LC Almeida, K Lima, MT Tavares, KB Waitman, LV Cost-Lotufo, ... Hematology, Transfusion and Cell Therapy 45, S218, 2023 | | 2023 |
| CARACTERIZAÇÃO DOS EFEITOS ANTINEOPLÁSICO DE UM POTENCIAL INIBIDOR HÍBRIDO PARA HDAC E BTK EM LEUCEMIA LINFOIDE CRÔNICA (LLC): EXPLORANDO SINERGIAS TERAPÊUTICAS COM VENETOCLAX A Garnique, J Carlos, K Lima, NS Parducci, MT Tavares, KB Waitman, ... Hematology, Transfusion and Cell Therapy 45, S155-S156, 2023 | | 2023 |
| Síntese e avaliação biológica de inibidores híbridos com vistas ao tratamento de neoplasias hematológicas VAM Souza, KB Waitman, SV Vassiliades, R Parise Filho Resumos, 2023 | | 2023 |
| Purine-derived phenylhydroxamate compounds reduce cell viability and modulate HDAC activity in hematological neoplasm models JAEG Carlos, LC Almeida, K Lima, MT Tavares, KB Waitman, LVC Lotufo, ... Anais, 2023 | | 2023 |
| Synthesis and biological evaluation of hybrid inhibitors for the treatment of hematologic malignancies VAM Souza, KB Waitman, MFZJ Toledo, MT Tavares, R Parise Filho Anais, 2023 | | 2023 |
| Design and synthesis of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment KB Waitman, MT Tavares, LC Almeida, JAEG Carlos, T Kronenberger, ... Anais, 2023 | | 2023 |
| PURINE-DERIVED PHENYLHYDROXAMATE COMPOUNDS INDUCES CELL DEATH IN HEMATOLOGICAL NEOPLASM MODELS J Carlos, LC Almeida, K Lima, MT Tavares, KB Waitman, LV Costa-Lotufo, ... Hematology, Transfusion and Cell Therapy 44, S157-S158, 2022 | | 2022 |
| A novel HDAC inhibitor potentiates Venetoclax-induced apoptosis in acute myeloid leukemia cells J Carlos, LC Almeida, K Lima, MT Tavares, KB Waitman, LV Costa-Lotufo, ... Hematology, Transfusion and Cell Therapy 44, S158-S159, 2022 | | 2022 |
| Design of new potential PI3Kį and HDAC6 hybrid inhibitors for cancer treatment KB Waitman, MT Tavares, MFZJ Toledo, R Parise-Filho, LC Almeida, ... | | 2022 |
